RecruitingPhase I/IIEN originalLymphoma

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

NCT07730515Original on ClinicalTrials.gov ↗
⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

In this study, the XNW5004 tablets combined with CHOP/CHOEP will be used for the treatment of newly diagnosed PTCL patients.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek 18-75 lat, bez ograniczeń co do płci
  • •Potwierdzony rozpoznaniem obwodowy chłoniak T-komórkowy
  • •Brak wcześniejszego leczenia tego nowotworu
  • •Co najmniej jedno widoczne powiększone węzły chłonne (przekrój ponad 1,5 cm) lub zmiana poza węzłami (ponad 1,0 cm)
  • •Przewidywana długość życia co najmniej 12 tygodni
  • •Dobry stan ogólny (możliwość wykonywania zwykłych czynności)
  • •Prawidłowa funkcja krwi, wątroby, nerek i serca
  • •Dla kobiet w wieku rozrodczym: ujemny test ciąży i zgodę na antykoncepcję

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
75 Years
Last updated (source)
July 29, 2026
Sex
No restrictions

Therapies / drugs in trial

XNW5004 combined with CHOP (incremental)XNW5004 combined with CHOEP (incremental)XNW5004 combined with CHOP (extended)XNW5004 combined with CHOEP (extended)

Locations (1)

Shanghai Cancer Center

Shanghai, China

Trial contact

Linlin.li Li

linlin.li@evopointbio.com18678888561

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Open original on ClinicalTrials.gov ↗Have questions? Contact us

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/29/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.